International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: https://doi.org/10.5281/zenodo.14557159
Original Research Article
Focal Seizures Induced by Non Ketotic Hyperglycemia in A Known Case of Type 2 Diabetes Mellitus
Published
Dec. 26, 2024
Abstract

Background: Focal seizures are a notable complication in patients with poorly controlled diabetes, particularly in the context of non-ketotichyperglycemia (NKH). Seizures associated with NKH are refractory to conventional antiepileptic drugs (AEDs) but respond effectively to glycemic control. This study evaluates the efficacy of insulin and rehydration over AEDs in managing NKH-induced seizures, highlighting the importance of early blood glucose monitoring in seizure presentations. Methods: A single-case observational study was conducted on a 58-year-old female with type 2 diabetes mellitus presenting with focal seizures. Diagnostic evaluations included blood glucose levels, serum osmolality, and imaging studies. The patient received both AEDs and insulin-based therapy, and seizure outcomes were monitored. Results: Despite maximum doses of phenytoin, seizures persisted until blood glucose levels were normalized through insulin therapy and hydration. The patient’s seizures resolved completely following glycemic correction, allowing successful withdrawal of AEDs. Conclusion: Insulin and hydration are more effective than AEDs in managing NKHinduced focal seizures. Early recognition of hyperglycemia and appropriate glycemic management can prevent unnecessary AED use and improve outcomes.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
2470 Views
252 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved